KR20210056349A - 단백질 및 폴리알콕시 지방 아실 계면활성제를 포함하는 조성물 - Google Patents

단백질 및 폴리알콕시 지방 아실 계면활성제를 포함하는 조성물 Download PDF

Info

Publication number
KR20210056349A
KR20210056349A KR1020217007252A KR20217007252A KR20210056349A KR 20210056349 A KR20210056349 A KR 20210056349A KR 1020217007252 A KR1020217007252 A KR 1020217007252A KR 20217007252 A KR20217007252 A KR 20217007252A KR 20210056349 A KR20210056349 A KR 20210056349A
Authority
KR
South Korea
Prior art keywords
composition
protein
fatty acyl
formula
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020217007252A
Other languages
English (en)
Korean (ko)
Inventor
조슈아 에스. 캣츠
수잔 엘. 조단
Original Assignee
다우 글로벌 테크놀로지스 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다우 글로벌 테크놀로지스 엘엘씨 filed Critical 다우 글로벌 테크놀로지스 엘엘씨
Publication of KR20210056349A publication Critical patent/KR20210056349A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
KR1020217007252A 2018-09-10 2019-09-06 단백질 및 폴리알콕시 지방 아실 계면활성제를 포함하는 조성물 Withdrawn KR20210056349A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862729140P 2018-09-10 2018-09-10
US62/729,140 2018-09-10
US201962850688P 2019-05-21 2019-05-21
US62/850,688 2019-05-21
PCT/US2019/049904 WO2020055679A2 (en) 2018-09-10 2019-09-06 A composition comprising a protein and a polyalkoxy fatty acyl surfactant

Publications (1)

Publication Number Publication Date
KR20210056349A true KR20210056349A (ko) 2021-05-18

Family

ID=68000095

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217007252A Withdrawn KR20210056349A (ko) 2018-09-10 2019-09-06 단백질 및 폴리알콕시 지방 아실 계면활성제를 포함하는 조성물

Country Status (6)

Country Link
US (1) US20260115292A1 (https=)
EP (1) EP3849519B1 (https=)
JP (1) JP2022500376A (https=)
KR (1) KR20210056349A (https=)
CN (1) CN112672734B (https=)
WO (1) WO2020055679A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022011314A2 (pt) * 2019-12-12 2022-08-23 Nutrition & Biosciences Usa 1 Llc Método para estabilizar uma proteína em solução aquosa durante a purificação e/ou concentração da proteína
US20230242580A1 (en) * 2020-07-15 2023-08-03 Nutrition & Biosciences Usa 1, Llc Bioprocess with reduced fouling on surfaces

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005011608A1 (de) * 2005-03-14 2006-09-21 Basf Ag Veresterte Alkylalkoxylate als schaumarme Tenside
CN108771655A (zh) * 2011-10-28 2018-11-09 诚信生物公司 含有氨基酸的蛋白质制剂
CA2861402C (en) * 2012-01-30 2021-10-12 Guy Casy Stabilized aqueous antibody compositions
DK3347031T3 (da) * 2015-09-11 2021-04-26 Nutrition & Biosciences Usa 1 Llc Sammensætning, der omfatter et protein og en polyalkoxyfedtforbindelse
DK3347403T3 (da) 2015-09-11 2020-06-29 Dow Global Technologies Llc Polyalkoxyfedtforbindelse

Also Published As

Publication number Publication date
CN112672734A (zh) 2021-04-16
WO2020055679A3 (en) 2020-05-28
EP3849519A2 (en) 2021-07-21
US20260115292A1 (en) 2026-04-30
WO2020055679A2 (en) 2020-03-19
JP2022500376A (ja) 2022-01-04
CN112672734B (zh) 2023-04-11
EP3849519B1 (en) 2022-09-21

Similar Documents

Publication Publication Date Title
AU735411B2 (en) Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies
US8298530B2 (en) Stable lyophilized pharmaceutical formulation of IgG antibodies
JP5405122B2 (ja) 低粘度のタンパク質製剤およびその用途
AU2013255413B2 (en) Pharmaceutical formulations of TNF-alpha antibodies
US11173208B2 (en) Liquid formulation comprising GM-CSF neutralizing compound
EP3615069B1 (en) N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
TWI836745B (zh) 含有抗人類ｔｓｌｐ受體抗體之醫藥組成物
JP2007045841A (ja) ヒト成長ホルモン水性製剤
WO2004019861A2 (en) Stable ph optimized formulation of a modified antibody
US20260115292A1 (en) Composition comprising a protein and a polyalkoxy fatty acyl surfactant
US20230065872A1 (en) Excipient compounds for protein processing
US9919051B2 (en) Liquid formulation comprising GM-CSF neutralizing compound
JP6339578B2 (ja) Ｇｍ−ｃｓｆ中和化合物を含む凍結乾燥製剤
WO2018152165A1 (en) Excipient compounds for protein processing
US20210322554A1 (en) A composition comprising a protein and a polyalkoxy fatty acyl surfactant
KR20220140487A (ko) 단백질 생물 공정
CA3059369C (en) N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20210310

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20220823

Comment text: Request for Examination of Application

A302 Request for accelerated examination
PA0302 Request for accelerated examination

Patent event date: 20230321

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230418

Patent event code: PE09021S01D

PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20230911

WITB Written withdrawal of application